Synergy and Mode of Action of Ceftazidime plus Quercetin or Luteolin on Streptococcus pyogenes

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Siriwong, Supatcharee ^a   Thumanu, Kanjana ^b   Hengpratom, Tanaporn ^a   Eumkeb, Griangsak ^a  

^a SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

^b SYNCHROTRON LIGHT RESEARCH INSTITUTE PUBLIC ORGANIZATION   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTAZIDIME; LUTEOLIN; NISIN; NUCLEIC ACID; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLINASE; PEPTIDOGLYCAN; PROTEIN; QUERCETIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CELL DIVISION; CELL MEMBRANE; CELL SHAPE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ASSAY; INFRARED SPECTROSCOPY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STREPTOCOCCUS PYOGENES; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84947969396     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/759459     Document Type: Article

References (57)

1. M. W. Cunningham, "Pathogenesis of group A streptococcal infections," ClinicalMicrobiology Reviews, vol. 13, no. 3, pp.470-511, 2000.
2. S. S. Y. Wong and K.-Y. Yuen, "Streptococcus pyogenes and reemergence of scarlet fever as a public health problem," Emerging Microbes and Infections, vol. 1, article e2, 2012.
3. T. L. Lamagni, J. Darenberg, B. Luca-Harari et al., "Epidemiology of severe Streptococcus pyogenes disease in Europe," Journal of Clinical Microbiology, vol. 46, no. 7, pp. 2359-2367, 2008.
4. D. Passali, M. Lauriello, G. C. Passali, F. M. Passali, and L. Bellussi, "Group A streptococcus and its antibiotic resistance," Acta Otorhinolaryngologica Italica, vol. 27, no. 1, pp. 27-32, 2007.
5. J. Sutcliffe, A. Tait-Kamradt, and L. Wondrack, "Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system," Antimicrobial Agents and Chemotherapy, vol. 40, no. 8, pp. 1817-1824, 1996.
6. D. Gür, M. Özalp, B. Sümerkan et al., "Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey," International Journal of Antimicrobial Agents, vol. 19, no. 3, pp. 207-211, 2002.
7. I. Brook, "Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis," International Journal of Pediatric Otorhinolaryngology, vol. 71, no. 10, pp. 1501-1508, 2007.
8. I. Brook, "Cephalosporins in overcoming β-lactamaseproducing bacteria and preservation of the interfering bacteria in the treatment of otitis, sinusitis and tonsillitis," Expert Review of Anti-Infective Therapy, vol. 5, no. 6, pp. 939-950, 2007.
9. Thailand National Antimicrobial Rresistance Surveillance Center, "Antibiogram 2014," in Proceedings of the NARST Annual International Conference, Bangkok, Thailand, January-March 2014.
10. S. R. Norrby, "Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics," Medical Toxicology and Adverse Drug Experience, vol. 1, no. 1, pp. 32-46, 1986.
11. B. Mittra, A. Saha, A. R. Chowdhury et al., "Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis,"MolecularMedicine, vol. 6, no. 6, pp. 527-541, 2000.
12. K. K. Chiruvella, A. Mohammed, G. Dampuri, R. G. Ghanta, and S. C. Raghavan, "Phytochemical and antimicrobial studies of methyl angolensate and luteolin-7-O-glucoside isolated from callus cultures of Soymida febrifuga," International Journal of Biomedical Science, vol. 3, no. 4, pp. 269-278, 2007.
13. P.-C. Lv, H.-Q. Li, J.-Y. Xue, L. Shi, and H.-L. Zhu, "Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents," European Journal of Medicinal Chemistry, vol. 44, no. 2, pp. 908-914, 2009.
14. Q. Wang and M. Xie, "Antibacterial activity and mechanism of luteolin on Staphylococcus aureus," Wei Sheng Wu Xue Bao, vol. 50, no. 9, pp. 1180-1184, 2010.
15. A. Plaper, M. Golob, I. Hafner, M. Oblak, T. Šolmajer, and R. Jerala, "Characterization of quercetin binding site on DNA gyrase," Biochemical and Biophysical Research Communications, vol. 306, no. 2, pp. 530-536, 2003.
16. A. M. L. Hossion, Y. Zamami, R.K. Kandahary et al., "Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents," Journal of Medicinal Chemistry, vol. 54, no. 11, pp. 3686-3703, 2011.
17. R. González-Segovia, J. L. Quintanar, E. Salinas, R. Ceballos- Salazar, F. Aviles-Jiménez, and J. Torres-López, "Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig," Journal of Gastroenterology, vol. 43, no. 6, pp. 441-447, 2008.
18. M. Li and Z. Xu, "Quercetin in a lotus leaves extract may be responsible for antibacterial activity," Archives of Pharmacal Research, vol. 31, no. 5, pp. 640-644, 2008.
19. S. S. A.-L. Al-Saif, N. Abdel-Raouf, H. A. El-Wazanani, and I. A. Aref, "Antibacterial substances from marine algae isolated from Jeddah coast of Red sea, Saudi Arabia," Saudi Journal of Biological Sciences, vol. 21, no. 1, pp. 57-64, 2014.
20. A. M. L. Hossion and K. Sasaki, "Novel quercetin glycosides as potent anti-MRSA and anti-VRE agents," Recent Patents on Anti-Infective Drug Discovery, vol. 8, no. 3, pp. 198-205, 2013.
21. S. M. Razavi, S. Zahri, G. Zarrini, H. Nazemiyeh, and S. Mohammadi, "Biological activity of quercetin-3-O-glucoside, a known plant flavonoid," Russian Journal of Bioorganic Chemistry, vol. 35, no. 3, pp. 376-378, 2009.
22. G. Eumkeb, S. Sakdarat, and S. Siriwong, "Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime," Phytomedicine, vol. 18, no. 1, pp. 40-45, 2010.
23. F. A. Ramos, Y. Takaishi, M. Shirotori et al., "Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin," Journal of Agricultural and Food Chemistry, vol. 54, no. 10, pp. 3551-3557, 2006.
24. G. Eumkeb, S. Siriwong, and K. Thumanu, "Synergistic activity of luteolin and amoxicillin combination against amoxicillinresistant Escherichia coli and mode of action," Journal of Photochemistry and Photobiology B: Biology, vol. 117, pp. 247-253, 2012.
25. V. Gopu, C. K. Meena, P. H. Shetty, and Y. He, "Quercetin influences quorum sensing in food borne bacteria: in-vitro and in-silico evidence," PLoS ONE, vol. 10, no. 8, Article ID e0134684, 2015.
26. H. M. Al-Qadiri, N. I. Al-Alami, M. A. Al-Holy, and B. A. Rasco, "Using Fourier transform infrared (FT-IR) absorbance spectroscopy and multivariate analysis to study the effect of chlorine-induced bacterial injury in water," Journal of Agricultural and Food Chemistry, vol. 56, no. 19, pp. 8992-8997, 2008.
27. M. Lin, M. Al-Holy, H. Al-Qadiri et al., "Discrimination of intact and injured Listeria monocytogenes by fourier transform infrared spectroscopy and principal component analysis," Journal of Agricultural and FoodChemistry, vol. 52, no. 19, pp. 5769-5772, 2004.
28. R. M. E. Richards and D. K. L. Xing, "In vitro evaluation of the antimicrobial activities of selected lozenges," Journal of Pharmaceutical Sciences, vol. 82, no. 12, pp. 1218-1220, 1993.
29. I. X. Liu, D. G. Durham, and R. M. E. Richards, "Baicalin synergy with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other β-lactam-resistant strains of S. aureus," Journal of Pharmacy and Pharmacology, vol. 52, no. 3, pp. 361-366, 2000.
30. Clinical Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically," in Clinical and Laboratory Standards Institute Document M07-A9, A. W. Matthew, R. C. Franklin, A. C. William et al., Eds., pp. 16-34, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2012.
31. L. D. Sabath, "Synergy of antibacterial substances by apparently known mechanisms," Antimicrobial Agents and Chemotherapy, vol. 7, pp. 210-217, 1967.
32. M. B. Marques, E. S. Brookings, S. A. Moser, P. B. Sonke, and K. B. Waites, "Comparative in vitro antimicrobial susceptibilities of nosocomial isolates ofAcinetobacter baumannii and synergistic activities of nine antimicrobial combinations," Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 881-885, 1997.
33. D. Wojnicz and S. Jankowski, "Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains," International Journal of Antimicrobial Agents, vol. 29, no. 6, pp. 700-704, 2007.
34. R. L. White, D. S. Burgess, M. Manduru, and J. A. Bosso, "Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test," Antimicrobial Agents and Chemotherapy, vol. 40, no. 8, pp. 1914-1918, 1996.
35. G. M. Eliopoulos and R. C. Moellering, "Antimicrobial combinations," in Antibiotic in Laboratory Medicine, V. Lorian, Ed., pp. 330-396, Williams andWilkins, Baltimore, Md, USA, 1996.
36. L. Shen, D. Liu, M. Li et al., "Mechanism of action of recombinant acc-royalisin from royal jelly of Asian honeybee against gram-positive bacteria," PLoS ONE, vol. 7, no. 10, Article ID e47194, 2012.
37. K. Zhou, W. Zhou, P. Li, G. Liu, J. Zhang, and Y. Dai, "Mode of action of pentocin 31-1: an antilisteria bacteriocin produced by Lactobacillus pentosus from Chinese traditional ham," Food Control, vol. 19, no. 8, pp. 817-822, 2008.
38. Y. Teethaisong, N. Autarkool, K. Sirichaiwetchakoon, P. Krubphachaya, S. Kupittayanant, and G. Eumkeb, "Synergistic activity andmechanismof action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus," Journal of Biomedical Science, vol. 21, no. 1, article 90, 2014.
39. R.M. E. Richards, J. Z. Xing, D.W. Gregory, and D. Marshall, "Mechanism of sulphadiazine enhancement of trimethoprim activity against sulphadiazine-resistant Enterococcus faecalis," Journal of Antimicrobial Chemotherapy, vol. 36, no. 4, pp. 607-618, 1995.
40. K. E. Eboigbodin and C. A. Biggs, "Characterization of the extracellular polymeric substances produced by Escherichia coli using infrared spectroscopic, proteomic, and aggregation studies," Biomacromolecules, vol. 9, no. 2, pp. 686-695, 2008.
41. D. Toubas, M. Essendoubi, I. Adt, J.-M. Pinon, M. Manfait, and G. D. Sockalingum, "FTIR spectroscopy in medical mycology: applications to the differentiation and typing of Candida," Analytical and Bioanalytical Chemistry, vol. 387, no. 5, pp. 1729-1737, 2007.
42. K. Becker, N. Al Laham, W. Fegeler, R. A. Proctor, G. Peters, and C. von Eiff, "Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small-colony variants," Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3274-3278, 2006.
43. G. Eumkeb, S. Siriwong, S. Phitaktim, N. Rojtinnakorn, and S. Sakdarat, "Synergistic activity and mode of action of flavonoids isolated from smaller galangal and amoxicillin combinations against amoxicillin-resistant Escherichia coli," Journal of Applied Microbiology, vol. 112, no. 1, pp. 55-64, 2012.
44. D. Helm and D. Naumann, "Identification of some bacterial cell components by FT-IR spectroscopy," FEMS Microbiology Letters, vol. 126, no. 1, pp. 75-79, 1995.
45. S. Garip, A. C. Gozen, and F. Severcan, "Use of Fourier transform infrared spectroscopy for rapid comparative analysis of Bacillus and Micrococcus isolates," Food Chemistry, vol. 113, no. 4, pp. 1301-1307, 2009.
46. R. J. Boon and A. S. Beale, "Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes," Antimicrobial Agents and Chemotherapy, vol. 31, no. 8, pp. 1204-1209, 1987.
47. I. Brook, "The role of beta-lactamase-producing-bacteria in mixed infections," BMC Infectious Diseases, vol. 9, article 202, 2009.
48. M. Kansiz, P. Heraud, B. Wood, F. Burden, J. Beardall, and D. McNaughton, "Fourier transform infrared microspectroscopy and chemometrics as a tool for the discrimination of cyanobacterial strains," Phytochemistry, vol. 52, no. 3, pp. 407-417, 1999.
49. M. Beekes, P. Lasch, andD. Naumann, "Analytical applications of Fourier transform-infrared (FT-IR) spectroscopy in microbiology and prion research," Veterinary Microbiology, vol. 123, no. 4, pp. 305-319, 2007.
50. D. Naumann, "Infrared spectroscopy in microbiology," in Encyclopedia of Analytical Chemistry, R. A. Myers, Ed., pp. 102-131, JohnWiley & Sons, Chichester, UK, 2000.
51. H. M. Al-Qadiri, N. I. Al-Alami, M. Lin, M. Al-Holy, A. G. Cavinato, and B. A. Rasco, "Studying of the bacterial growth phases using fourier transform infrared spectroscopy and multivariate analysis," Journal of Rapid Methods & Automation in Microbiology, vol. 16, no. 1, pp. 73-89, 2008.
52. J. C. Brown, J. Wang, L. Kasman, X. Jiang, and V. Haley- Zitlin, "Activities ofmuscadine grape skin and quercetin against Helicobacter pylori infection in mice," Journal of AppliedMicrobiology, vol. 110, no. 1, pp. 139-146, 2011.
53. A. M. L. Hossion, N. Otsuka, R. K. Kandahary et al., "Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents," Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 17, pp. 5349-5352, 2010.
54. M. Miski, A. Ulubelen, C. Johansson, and T. J. Mabry, "Antibacterial activity studies of flavonoids from Salvia palaestina," Journal of Natural Products, vol. 46, no. 6, pp. 874-875, 1983.
55. D. F. Basri, N. M. Zin, N. S. Bakar, F. Rahmat, and M. Mohtar, "Synergistic effects of phytochemicals and oxacillin on laboratory passage-derived vancomycin-intermediate Staphylococcus aureus strain," Journal of Medical Sciences, vol. 8, no. 2, pp. 131-136, 2008.
56. G. Eumkeb and S. Chukrathok, "Synergistic activity andmechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae," Phytomedicine, vol. 20, no. 3-4, pp. 262-269, 2013.
57. B. D. Reed, W. Huck, and P. Zazove, "Treatment of β-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with β-lactamase-producing organisms in the pharynx," Journal of Family Practice, vol. 32, no. 2, pp. 138-144, 1991.